Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7841 - 7848 of 12008 results
Mintz Highlights Legal Updates and Trends in Monthly TCPA Digest
August 25, 2016| Blog| Viewpoint
Third Circuit Affirms Dismissal of Exclusive Dealing Antitrust Suit Against Hospital and Physician Group
August 25, 2016| Blog| Viewpoint
Three Immigration Lawyers Sanctioned by the SEC for Brokering EB-5 Investments
August 24, 2016| Blog| Viewpoint
Massachusetts Determination of Need Regulation Overhaul
August 24, 2016| Blog| Viewpoint
Industrial Espionage and the Defend Trade Secrets Act
August 24, 2016| Blog| Viewpoint
IRS Relaxes Restrictions on Management Contracts for Bond-Financed Facilities
August 24, 2016| Advisory| Viewpoint
No Resuscitation of Hospital’s Exclusive Dealing Antitrust Suit against Competing Hospitals and Physicians
August 23, 2016| Alert| Viewpoint
Eddie Bauer Latest Victim of POS Malware Attack
August 23, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|